{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:19:22Z","timestamp":1774941562824,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81371271"],"award-info":[{"award-number":["81371271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic Research Project of the Educational Department of Liaoning Province","award":["LJKQZ20222350"],"award-info":[{"award-number":["LJKQZ20222350"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial dysfunction and neuronal damage are major sign of cytopathology in Huntington\u2019s disease (HD), a neurodegenerative disease. Ubiquitin specific peptidase 11 (USP11) is a deubiquitinating enzyme involved in various physiological processes through regulating protein degradation. However, its specific role in HD is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To interfere with USP11 expression, adeno-associated viruses 2 containing USP11-specific shRNA were injected into the bilateral striatum of 12-week-old R6\/1 and WT mice. In vitro, the inducible PC12 cell model of HD was used in which the expression of an N-terminal truncation of huntingtin, with either wild type (Q23) or expanded polyglutamine (Q74) can be induced by the doxycycline. USP11 was knocked down to study its role in HD. The protein expression patterns in Q74 cells were quantified by label-free proteomics to further explore the target protein of USP11. Detecting the association between USP11 and Phosphatase and Tensin Homolog (PTEN) through Co-IP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Herein, USP11 was found to be upregulated in the striatum of R6\/1 mice (an HD model with gradual development of symptoms) in an age-dependent manner. The spontaneous HD was alleviated by silencing USP11, as evidenced by improved locomotor activity and spatial memory, attenuated striatal atrophy in R6\/1 mice, reduced accumulation of mutant huntingtin protein, and restored mitochondrial function in vitro and in vivo. The results of label-free proteomics revealed a significant change in the protein expression profile. Through functional enrichment, we focused on PTEN, known as a negative regulator of the AKT pathway. We demonstrated that USP11 downregulation promoted ubiquitination modification of PTEN and activated the AKT pathway, and PTEN overexpression reversed the effects of USP11 knockdown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, USP11 knockdown protects R6\/1 mouse neurons from oxidative stress by alleviating mitochondrial dysfunction, thereby preventing the HD progression. This is achieved by inhibiting PTEN expression, which in turn activates the AKT pathway. This study suggests that USP11-PTEN-AKT signaling pathway may be a new attractive therapeutic target for HD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-024-01061-w","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:33:32Z","timestamp":1736332412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ubiquitin specific peptidase 11 knockdown slows Huntington\u2019s disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway"],"prefix":"10.1186","volume":"31","author":[{"given":"Bai","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"113230","DOI":"10.1016\/j.bbr.2021.113230","volume":"408","author":"QD Angeles-L\u00f3pez","year":"2021","unstructured":"Angeles-L\u00f3pez QD, Garc\u00eda-Lara L, Aguirre-Pineda N, Casta\u00f1eda-Arellano R, Elizondo-Azuela G, P\u00e9rez-Severiano F, et al. The absence of the aryl hydrocarbon receptor in the R6\/1 transgenic mouse model of Huntington\u2019s disease improves the neurological phenotype. Behav Brain Res. 2021;408:113230. https:\/\/doi.org\/10.1016\/j.bbr.2021.113230.","journal-title":"Behav Brain Res"},{"issue":"1","key":"1061_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron. 2005;47(1):29\u201341. https:\/\/doi.org\/10.1016\/j.neuron.2005.06.005.","journal-title":"Neuron"},{"issue":"3","key":"1061_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/10799893.2019.1655051","volume":"39","author":"L Bao","year":"2019","unstructured":"Bao L, Li X, Lin Z. PTEN overexpression promotes glioblastoma death through triggering mitochondrial division and inactivating the AKT pathway. J Recept Signal Transduct Res. 2019;39(3):215\u201325. https:\/\/doi.org\/10.1080\/10799893.2019.1655051.","journal-title":"J Recept Signal Transduct Res"},{"issue":"7","key":"1061_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2174\/0929867323666160118095620","volume":"23","author":"S Basak","year":"2016","unstructured":"Basak S, Lu C, Basak A. Post-translational protein modifications of rare and unconventional types: implications in functions and diseases. Curr Med Chem. 2016;23(7):714\u201345. https:\/\/doi.org\/10.2174\/0929867323666160118095620.","journal-title":"Curr Med Chem"},{"issue":"10","key":"1061_CR5","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1007\/s12035-018-0956-5","volume":"55","author":"J Creus-Muncunill","year":"2018","unstructured":"Creus-Muncunill J, Ru\u00e9 L, Alcal\u00e1-Vida R, Badillos-Rodr\u00edguez R, Roman\u00ed-Aumedes J, Marco S, et al. Increased levels of rictor prevent mutant huntingtin-induced neuronal degeneration. Mol Neurobiol. 2018;55(10):7728\u201342. https:\/\/doi.org\/10.1007\/s12035-018-0956-5.","journal-title":"Mol Neurobiol"},{"issue":"1386","key":"1061_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1098\/rstb.1999.0448","volume":"354","author":"SW Davies","year":"1999","unstructured":"Davies SW, Turmaine M, Cozens BA, Raza AS, Mahal A, Mangiarini L, et al. From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington\u2019s disease. Philos Trans R Soc Lond B Biol Sci. 1999;354(1386):971\u20139. https:\/\/doi.org\/10.1098\/rstb.1999.0448.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"1061_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5(1):11. https:\/\/doi.org\/10.1038\/s41392-020-0107-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"1061_CR8","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1111\/jcmm.16838","volume":"25","author":"X Dong","year":"2021","unstructured":"Dong X, Cong S. DNM3OS regulates GAPDH expression and influences the molecular pathogenesis of Huntington\u2019s disease. J Cell Mol Med. 2021;25(18):9066\u201371. https:\/\/doi.org\/10.1111\/jcmm.16838.","journal-title":"J Cell Mol Med"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"106225","DOI":"10.1016\/j.nbd.2023.106225","volume":"184","author":"M Espina","year":"2023","unstructured":"Espina M, Di Franco N, Bra\u00f1as-Navarro M, Navarro IR, Brito V, Lopez-Molina L, et al. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington\u2019s disease R6\/1 mice. Neurobiol Dis. 2023;184:106225. https:\/\/doi.org\/10.1016\/j.nbd.2023.106225.","journal-title":"Neurobiol Dis"},{"key":"1061_CR10","doi-asserted-by":"publisher","first-page":"148321","DOI":"10.1016\/j.brainres.2023.148321","volume":"1807","author":"Y Fang","year":"2023","unstructured":"Fang Y, Zhao T, Ni H, Li Y, Zhu Y, Gao R, et al. USP11 exacerbates neuronal apoptosis after traumatic brain injury via PKM2-mediated PI3K\/AKT signaling pathway. Brain Res. 2023;1807:148321. https:\/\/doi.org\/10.1016\/j.brainres.2023.148321.","journal-title":"Brain Res"},{"issue":"1","key":"1061_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease. J Biol Chem. 2005;280(1):556\u201363. https:\/\/doi.org\/10.1074\/jbc.M410210200.","journal-title":"J Biol Chem"},{"issue":"52","key":"1061_CR12","doi-asserted-by":"publisher","first-page":"41299","DOI":"10.1074\/jbc.M008408200","volume":"275","author":"AS Hackam","year":"2000","unstructured":"Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst CA, Gan L, et al. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem. 2000;275(52):41299\u2013308. https:\/\/doi.org\/10.1074\/jbc.M008408200.","journal-title":"J Biol Chem"},{"issue":"6","key":"1061_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/s1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S, Bryson EA, Cordeli\u00e8res FP, Connors NC, Datta SR, Finkbeiner S, et al. The IGF-1\/AKT pathway is neuroprotective in Huntington\u2019s disease and involves huntingtin phosphorylation by AKT. Dev Cell. 2002;2(6):831\u20137. https:\/\/doi.org\/10.1016\/s1534-5807(02)00188-0.","journal-title":"Dev Cell"},{"issue":"11","key":"1061_CR14","doi-asserted-by":"publisher","first-page":"e2474","DOI":"10.1038\/cddis.2016.371","volume":"7","author":"AM Jacko","year":"2016","unstructured":"Jacko AM, Nan L, Li S, Tan J, Zhao J, Kass DJ, et al. De-ubiquitinating enzyme, USP11, promotes transforming growth factor \u03b2-1 signaling through stabilization of transforming growth factor \u03b2 receptor II. Cell Death Dis. 2016;7(11):e2474. https:\/\/doi.org\/10.1038\/cddis.2016.371.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1061_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2011","unstructured":"Jiang M, Wang J, Fu J, Du L, Jeong H, West T, et al. Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med. 2011;18(1):153\u20138. https:\/\/doi.org\/10.1038\/nm.2558.","journal-title":"Nat Med"},{"issue":"11","key":"1061_CR16","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s11064-017-2361-2","volume":"42","author":"X Jiang","year":"2017","unstructured":"Jiang X, Yu M, Ou Y, Cao Y, Yao Y, Cai P, et al. Downregulation of USP4 promotes activation of microglia and subsequent neuronal inflammation in rat spinal cord after Injury. Neurochem Res. 2017;42(11):3245\u201353. https:\/\/doi.org\/10.1007\/s11064-017-2361-2.","journal-title":"Neurochem Res"},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fonc.2016.00238","volume":"6","author":"A Karachitos","year":"2016","unstructured":"Karachitos A, Grobys D, Kulczy\u0144ska K, Sobusiak A, Kmita H. The association of VDAC with cell viability of PC12 model of Huntington\u2019s disease. Front Oncol. 2016;6:238. https:\/\/doi.org\/10.3389\/fonc.2016.00238.","journal-title":"Front Oncol"},{"issue":"12","key":"1061_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1631\/jzus.B1400180","volume":"15","author":"JY Ke","year":"2014","unstructured":"Ke JY, Dai CJ, Wu WL, Gao JH, Xia AJ, Liu GP, et al. USP11 regulates p53 stability by deubiquitinating p53. J Zhejiang Univ Sci B. 2014;15(12):1032\u20138. https:\/\/doi.org\/10.1631\/jzus.B1400180.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2019.03.033","volume":"151","author":"RB Laprairie","year":"2019","unstructured":"Laprairie RB, Bagher AM, Rourke JL, Zrein A, Cairns EA, Kelly MEM, et al. Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington\u2019s disease in the R6\/2 mouse model. Neuropharmacology. 2019;151:1\u201312. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.033.","journal-title":"Neuropharmacology"},{"issue":"Pt A","key":"1061_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.expneurol.2017.10.019","volume":"299","author":"D Luis-Ravelo","year":"2018","unstructured":"Luis-Ravelo D, Est\u00e9vez-Silva H, Barroso-Chinea P, Afonso-Oramas D, Salas-Hern\u00e1ndez J, Rodr\u00edguez-N\u00fa\u00f1ez J, et al. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington\u2019s disease. Exp Neurol. 2018;299(Pt A):137\u201347. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.019.","journal-title":"Exp Neurol"},{"issue":"6","key":"1061_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72(6):971\u201383. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E.","journal-title":"Cell"},{"issue":"4","key":"1061_CR22","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s12035-021-02698-y","volume":"59","author":"I Mees","year":"2022","unstructured":"Mees I, Tran H, Roberts A, Lago L, Li S, Roberts BR, et al. Quantitative phosphoproteomics reveals extensive protein phosphorylation dysregulation in the cerebral cortex of Huntington\u2019s disease mice prior to onset of symptoms. Mol Neurobiol. 2022;59(4):2456\u201371. https:\/\/doi.org\/10.1007\/s12035-021-02698-y.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1061_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/s0165-6147(00)01884-8","volume":"23","author":"LB Menalled","year":"2002","unstructured":"Menalled LB, Chesselet MF. Mouse models of Huntington\u2019s disease. Trends Pharmacol Sci. 2002;23(1):32\u20139. https:\/\/doi.org\/10.1016\/s0165-6147(00)01884-8.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1061_CR24","doi-asserted-by":"publisher","first-page":"e9793","DOI":"10.1371\/journal.pone.0009793","volume":"5","author":"LB Menalled","year":"2010","unstructured":"Menalled LB, Patry M, Ragland N, Lowden PA, Goodman J, Minnich J, et al. Comprehensive behavioral testing in the R6\/2 mouse model of Huntington\u2019s disease shows no benefit from CoQ10 or minocycline. PLoS ONE. 2010;5(3):e9793. https:\/\/doi.org\/10.1371\/journal.pone.0009793.","journal-title":"PLoS ONE"},{"issue":"22","key":"1061_CR25","doi-asserted-by":"publisher","first-page":"10952","DOI":"10.1073\/pnas.1814246116","volume":"116","author":"J Ochaba","year":"2019","unstructured":"Ochaba J, Fote G, Kachemov M, Thein S, Yeung SY, Lau AL, et al. IKK\u03b2 slows Huntington\u2019s disease progression in R6\/1 mice. Proc Natl Acad Sci U S A. 2019;116(22):10952\u201361. https:\/\/doi.org\/10.1073\/pnas.1814246116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1061_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11910-021-01093-3","volume":"21","author":"L Pan","year":"2021","unstructured":"Pan L, Feigin A. Huntington\u2019s disease: new frontiers in therapeutics. Curr Neurol Neurosci Rep. 2021;21(3):10. https:\/\/doi.org\/10.1007\/s11910-021-01093-3.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"1061_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41467-019-08481-x","volume":"10","author":"MK Park","year":"2019","unstructured":"Park MK, Yao Y, Xia W, Setijono SR, Kim JH, Vila IK, et al. PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression. Nat Commun. 2019;10(1):636. https:\/\/doi.org\/10.1038\/s41467-019-08481-x.","journal-title":"Nat Commun"},{"issue":"1","key":"1061_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, et al. Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry. 2006;59(1):57\u201363. https:\/\/doi.org\/10.1016\/j.biopsych.2005.06.003.","journal-title":"Biol Psychiatry"},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroimage.2016.06.023","volume":"139","author":"J P\u00e9pin","year":"2016","unstructured":"P\u00e9pin J, Francelle L, Carrillo-de Sauvage MA, de Longprez L, Gipchtein P, Cambon K, et al. In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington\u2019s disease. NeuroImage. 2016;139:53\u201364. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.06.023.","journal-title":"NeuroImage"},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.neuropharm.2014.07.021","volume":"89","author":"S Pietropaolo","year":"2015","unstructured":"Pietropaolo S, Bellocchio L, Ruiz-Calvo A, Cabanas M, Du Z, Guzm\u00e1n M, et al. Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington\u2019s disease. Neuropharmacology. 2015;89:368\u201374. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.07.021.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1061_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2010.12.013","volume":"54","author":"AC Piguet","year":"2011","unstructured":"Piguet AC, Dufour JF. PI(3)K\/PTEN\/AKT pathway. J Hepatol. 2011;54(6):1317\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2010.12.013.","journal-title":"J Hepatol"},{"issue":"10","key":"1061_CR32","doi-asserted-by":"publisher","first-page":"107768","DOI":"10.1016\/j.jbc.2024.107768","volume":"300","author":"T Qian","year":"2024","unstructured":"Qian T, Bai F, Zhang S, Xu Y, Wang Y, Yuan S, et al. USP11 deubiquitinates E-cadherin and maintains the luminal fate of mammary tumor cells to suppress breast cancer. J Biol Chem. 2024;300(10):107768. https:\/\/doi.org\/10.1016\/j.jbc.2024.107768.","journal-title":"J Biol Chem"},{"key":"1061_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107187119","author":"UN Ram\u00edrez-Jarqu\u00edn","year":"2022","unstructured":"Ram\u00edrez-Jarqu\u00edn UN, Sharma M, Zhou W, Shahani N, Subramaniam S. Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease. Proc Natl Acad Sci USA. 2022. https:\/\/doi.org\/10.1073\/pnas.2107187119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1061_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00018-023-05015-z","volume":"80","author":"E Rodr\u00edguez-Urgell\u00e9s","year":"2023","unstructured":"Rodr\u00edguez-Urgell\u00e9s E, Casas-Torremocha D, Sancho-Balsells A, Ballasch I, Garc\u00eda-Garc\u00eda E, Miquel-Rio L, et al. Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington\u2019s disease. Cell Mol Life Sci. 2023;80(12):367. https:\/\/doi.org\/10.1007\/s00018-023-05015-z.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1061_CR35","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41418-021-00907-8","volume":"29","author":"Y Rong","year":"2022","unstructured":"Rong Y, Fan J, Ji C, Wang Z, Ge X, Wang J, et al. USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating beclin 1. Cell Death Differ. 2022;29(6):1164\u201375. https:\/\/doi.org\/10.1038\/s41418-021-00907-8.","journal-title":"Cell Death Differ"},{"issue":"6","key":"1061_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12426","volume":"26","author":"U R\u00fcb","year":"2016","unstructured":"R\u00fcb U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW. Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol. 2016;26(6):726\u201340. https:\/\/doi.org\/10.1111\/bpa.12426.","journal-title":"Brain Pathol"},{"issue":"5","key":"1061_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.physbeh.2011.04.001","volume":"103","author":"DN Ruskin","year":"2011","unstructured":"Ruskin DN, Ross JL, Kawamura M Jr., Ruiz TL, Geiger JD, Masino SA. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6\/2 1J mouse model of Huntington\u2019s disease. Physiol Behav. 2011;103(5):501\u20137. https:\/\/doi.org\/10.1016\/j.physbeh.2011.04.001.","journal-title":"Physiol Behav"},{"issue":"10","key":"1061_CR38","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1172\/jci46305","volume":"121","author":"M Sadagurski","year":"2011","unstructured":"Sadagurski M, Cheng Z, Rozzo A, Palazzolo I, Kelley GR, Dong X, et al. IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest. 2011;121(10):4070\u201381. https:\/\/doi.org\/10.1172\/jci46305.","journal-title":"J Clin Invest"},{"issue":"10","key":"1061_CR39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/jmedgenet-2013-101796","volume":"50","author":"A Semaka","year":"2013","unstructured":"Semaka A, Kay C, Doty C, Collins JA, Bijlsma EK, Richards F, et al. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J Med Genet. 2013;50(10):696\u2013703. https:\/\/doi.org\/10.1136\/jmedgenet-2013-101796.","journal-title":"J Med Genet"},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-0716-3441-7_5","volume":"2714","author":"A Singh","year":"2024","unstructured":"Singh A, Copeland MM, Kundrotas PJ, Vakser IA. GRAMM web server for protein docking. Methods Mol Biol. 2024;2714:101\u201312. https:\/\/doi.org\/10.1007\/978-1-0716-3441-7_5.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1061_CR41","doi-asserted-by":"publisher","first-page":"fcad010","DOI":"10.1093\/braincomms\/fcad010","volume":"5","author":"EJ Smith","year":"2023","unstructured":"Smith EJ, Sathasivam K, Landles C, Osborne GF, Mason MA, Gomez-Paredes C, et al. Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches. Brain Commun. 2023;5(1):fcad010. https:\/\/doi.org\/10.1093\/braincomms\/fcad010.","journal-title":"Brain Commun"},{"issue":"10","key":"1061_CR42","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/NEN.0b013e3181f530ec","volume":"69","author":"A Snyder-Keller","year":"2010","unstructured":"Snyder-Keller A, McLear JA, Hathorn T, Messer A. Early or late-stage anti-N-terminal huntingtin intrabody gene therapy reduces pathological features in B6.HDR6\/1 mice. J Neuropathol Exp Neurol. 2010;69(10):1078\u201385. https:\/\/doi.org\/10.1097\/NEN.0b013e3181f530ec.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1061_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147709","author":"H Sun","year":"2024","unstructured":"Sun H, Li M, Li Y, Zheng N, Li J, Li X, et al. Gastrodin improves the activity of the ubiquitin-proteasome system and the autophagy-lysosome pathway to degrade mutant huntingtin. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25147709.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1061_CR44","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1021\/acschemneuro.9b00185","volume":"10","author":"JR Sundaram","year":"2019","unstructured":"Sundaram JR, Wu Y, Lee IC, George SE, Hota M, Ghosh S, et al. PromISR-6, a Guanabenz Analogue, improves Cellular Survival in an experimental model of Huntington\u2019s Disease. ACS Chem Neurosci. 2019;10(8):3575\u201389. https:\/\/doi.org\/10.1021\/acschemneuro.9b00185.","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"1061_CR45","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ijrobp.2024.01.220","volume":"119","author":"Y Tang","year":"2024","unstructured":"Tang Y, Wang T, Gu L, Xu Y, Yang Z, Zhu W, et al. USP11 exacerbates Radiation-Induced Pneumonitis by activating endothelial cell inflammatory response via OTUD5-STING signaling. Int J Radiat Oncol Biol Phys. 2024;119(4):1261\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.220.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1061_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1006\/exnr.1995.1029","volume":"133","author":"LB Thomas","year":"1995","unstructured":"Thomas LB, Gates DJ, Richfield EK, O\u2019Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington\u2019s disease and other neuropathological conditions. Exp Neurol. 1995;133(2):265\u201372. https:\/\/doi.org\/10.1006\/exnr.1995.1029.","journal-title":"Exp Neurol"},{"issue":"2","key":"1061_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"BM Virginia","year":"2012","unstructured":"Virginia BM, Soshana PS, Allison E, Clive NS, Alvin RK, Malcolm C, et al. Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell. 2012;11(2):264\u201378. https:\/\/doi.org\/10.1016\/j.stem.2012.04.027.","journal-title":"Cell Stem Cell"},{"key":"1061_CR48","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302018","author":"K Voelkl","year":"2023","unstructured":"Voelkl K, Guti\u00e9rrez-\u00c1ngel S, Keeling S, Koyuncu S, da Silva Padilha M, Feigenbutz D, et al. Neuroprotective effects of hepatoma-derived growth factor in models of Huntington\u2019s disease. Life Sci Alliance. 2023. https:\/\/doi.org\/10.26508\/lsa.202302018.","journal-title":"Life Sci Alliance"},{"issue":"W1","key":"1061_CR49","doi-asserted-by":"publisher","first-page":"W140","DOI":"10.1093\/nar\/gkaa275","volume":"48","author":"D Wang","year":"2020","unstructured":"Wang D, Liu D, Yuchi J, He F, Jiang Y, Cai S, et al. MusiteDeep: a deep-learning based webserver for protein post-translational modification site prediction and visualization. Nucleic Acids Res. 2020;48(W1):W140\u20136. https:\/\/doi.org\/10.1093\/nar\/gkaa275.","journal-title":"Nucleic Acids Res"},{"key":"1061_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081979","author":"A White","year":"2022","unstructured":"White A, McGlone A, Gomez-Pastor R. Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington\u2019s Disease. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10081979.","journal-title":"Biomedicines"},{"key":"1061_CR51","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/ncomms4214","volume":"5","author":"HC Wu","year":"2014","unstructured":"Wu HC, Lin YC, Liu CH, Chung HC, Wang YT, Lin YW, et al. USP11 regulates PML stability to control notch-induced malignancy in brain tumours. Nat Commun. 2014;5:3214. https:\/\/doi.org\/10.1038\/ncomms4214.","journal-title":"Nat Commun"},{"issue":"44","key":"1061_CR52","doi-asserted-by":"publisher","first-page":"14708","DOI":"10.1523\/jneurosci.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B. BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci. 2010;30(44):14708\u201318. https:\/\/doi.org\/10.1523\/jneurosci.1637-10.2010.","journal-title":"J Neurosci"},{"issue":"1","key":"1061_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12031-015-0644-0","volume":"58","author":"Z Xu","year":"2016","unstructured":"Xu Z, Li X, Chen J, Zhao J, Wang J, Ji Y, et al. USP11, deubiquitinating enzyme, Associated with neuronal apoptosis following intracerebral hemorrhage. J Mol Neurosci. 2016;58(1):16\u201327. https:\/\/doi.org\/10.1007\/s12031-015-0644-0.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"1061_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bbr.2011.09.041","volume":"226","author":"DH Zeef","year":"2012","unstructured":"Zeef DH, Vlamings R, Lim LW, Tan S, Janssen ML, Jahanshahi A, et al. Motor and non-motor behaviour in experimental Huntington\u2019s disease. Behav Brain Res. 2012;226(2):435\u20139. https:\/\/doi.org\/10.1016\/j.bbr.2011.09.041.","journal-title":"Behav Brain Res"},{"key":"1061_CR55","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.omtm.2021.01.015","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu T, Xu S, Gao P, Dong W, Liu W, et al. A pro-inflammatory mediator USP11 enhances the stability of p53 and inhibits KLF2 in intracerebral hemorrhage. Mol Ther Methods Clin Dev. 2021;21:681\u201392. https:\/\/doi.org\/10.1016\/j.omtm.2021.01.015.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1061_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","volume":"11","author":"J Zheng","year":"2018","unstructured":"Zheng J, Winderickx J, Franssens V, Liu B. A Mitochondria-Associated oxidative stress perspective on Huntington\u2019s disease. Front Mol Neurosci. 2018;11:329. https:\/\/doi.org\/10.3389\/fnmol.2018.00329.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"1061_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10495-006-3714-5","volume":"11","author":"Y Zhu","year":"2006","unstructured":"Zhu Y, Hoell P, Ahlemeyer B, Krieglstein J. PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis. 2006;11(2):197\u2013207. https:\/\/doi.org\/10.1007\/s10495-006-3714-5.","journal-title":"Apoptosis"},{"key":"1061_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mcn.2014.05.004","volume":"64","author":"L Zhu","year":"2015","unstructured":"Zhu L, Bi W, Lu D, Zhang C, Shu X, Wang H, et al. Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation. Mol Cell Neurosci. 2015;64:74\u201383. https:\/\/doi.org\/10.1016\/j.mcn.2014.05.004.","journal-title":"Mol Cell Neurosci"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-01061-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-024-01061-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-01061-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:11:07Z","timestamp":1744866667000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-01061-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1186\/s10020-024-01061-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4923322\/v1","asserted-by":"object"}]},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the reference text citations are incorrectly linked with the reference list and it has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments have been approved by the Medical Ethics Committee of Shengjing Hospital of China Medical University and followed the Guide for the Care and Use of Laboratory Animals (Eighth Edition).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}